Development of a new colloidal drug carrier from chemically-modified cyclodextrins: Nanospheres and influence of physicochemical and technological factors on particle size
暂无分享,去创建一个
Dominique Duchêne | Denis Wouessidjewe | M. Skiba | F. Puisieux | D. Duchěne | Francis Puisieux | D. Wouessidjewe | Mohamed Skiba
[1] Y. Kawashima,et al. Spherical Crystallization: Direct Spherical Agglomeration of Salicylic Acid Crystals During Crystallization , 1982, Science.
[2] T Niwa,et al. Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method. , 1990, Journal of pharmaceutical sciences.
[3] V. Lenaerts,et al. Development of a nanoparticle controlled-release formulation for human use , 1986 .
[4] Hervé Galons,et al. Formation of amphiphilic cyclodextrins via hydrophobic esterification at the secondary hydroxyl face , 1991 .
[5] D. Dalgleish. Coagulation of renneted bovine casein micelles: dependence on temperature, calcium ion concentration and ionic strength , 1983, Journal of Dairy Research.
[6] M. Skiba,et al. Evaluation of gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules, loaded with indomethacin , 1995 .